PlexBio Co., Ltd. (6572.TWO)
TWD 11.3
(-4.24%)
TWD 11.3
(-4.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -29.26 Million | -71.44 Million | -84.33 Million | -110.79 Million | - |
| Net Income | -58.53 Million | -53.13 Million | -131.58 Million | -141.06 Million | - |
| Depreciation & Amortization | 17.98 Million | 20.07 Million | 24.54 Million | 25.29 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 2.29 Million | 542 Thousand | 651 Thousand | 1.87 Million | - |
| Change in working capital | 10.35 Million | -38.92 Million | 21.35 Million | -1.25 Million | - |
| Other non-cash items | -8 Million | -2.83 Million | -2.08 Million | -4.46 Million | - |
| Investing Cash Flow | 16.93 Million | 42.06 Million | 126.29 Million | -24.05 Million | - |
| Investments in PPE | -3.26 Million | -2.01 Million | -11.6 Million | -6.49 Million | - |
| Acquisitions | 222 Thousand | - | - | - | - |
| Investment purchases | - | - | - | -17.32 Million | -295.7 Million |
| Sales/Maturities of investments | 20 Million | 44.5 Million | 137.22 Million | - | - |
| Other Investing Activities | -22 Thousand | -877 Thousand | -248 Thousand | -301 Thousand | - |
| Financing Cash Flow | -18.98 Million | -8.88 Million | -8.91 Million | 3.34 Million | - |
| Debt repayment | -8.61 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 4.8 Million | 9.15 Million | 745.04 Million |
| Other Financing Activities | -10.37 Million | - | -3.02 Million | 3.02 Million | - |
| Accounts receivables | 1.26 Million | - | - | - | - |
| Accounts payables | -309 Thousand | - | - | - | - |
| Inventory | -5.08 Million | 11.78 Million | 3.61 Million | -10.55 Million | - |
| Other working capital | 14.17 Million | - | - | - | - |
| Cash at beginning of period | 310.35 Million | 348.28 Million | 315.49 Million | 446.63 Million | - |
| Cash at end of period | 278.87 Million | 310.35 Million | 348.28 Million | 315.49 Million | - |
| Capital Expenditure | -3.26 Million | -2.01 Million | -11.6 Million | -6.49 Million | - |
| Effect of forex changes on cash | -162 Thousand | 340 Thousand | -264 Thousand | 367 Thousand | - |
| Net cash flow / Change in cash | -31.48 Million | -37.92 Million | 32.78 Million | -131.13 Million | - |
| Free Cash Flow | -32.53 Million | -73.46 Million | -95.93 Million | -117.28 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -20.36 Million | -20.36 Million | -58.53 Million | -27.97 Million | -13.98 Million | -30.55 Million |
| Depreciation & Amortization | 4.58 Million | 4.58 Million | 17.98 Million | 9.3 Million | 4.65 Million | 8.68 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 557 Thousand | 557 Thousand | 2.29 Million | - | 364.5 Thousand | - |
| Change in working capital | -9.47 Million | -9.47 Million | 10.35 Million | 6.99 Million | 5.15 Million | 3.35 Million |
| Other non-cash items | 65.88 Million | 65.88 Million | -8 Million | 184 Thousand | -1.92 Million | 736 Thousand |
| Investing Cash Flow | -399 Thousand | -399 Thousand | 16.93 Million | 216.2 Million | 108.1 Million | -199.26 Million |
| Investments in PPE | -656 Thousand | -656 Thousand | -3.26 Million | -1.1 Million | -550.5 Thousand | -1.96 Million |
| Acquisitions | 521 Thousand | - | - | -521 Thousand | - | 743 Thousand |
| Investment purchases | - | - | - | 197.85 Million | - | -197.85 Million |
| Sales/Maturities of investments | - | - | 20 Million | 20 Million | - | - |
| Other Investing Activities | 257 Thousand | 257 Thousand | -22 Thousand | -28 Thousand | 108.65 Million | 6000.00 |
| Financing Cash Flow | -2.17 Million | -2.17 Million | -18.98 Million | -4.17 Million | -2.08 Million | -14.81 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.17 Million | -2.17 Million | -10.37 Million | -4.17 Million | -2.08 Million | -14.81 Million |
| Accounts receivables | -2.44 Million | -2.44 Million | - | 43 Thousand | 54 Thousand | 1.22 Million |
| Accounts payables | 949 Thousand | - | - | -1.51 Million | - | 1.2 Million |
| Inventory | 389 Thousand | 389 Thousand | -5.08 Million | 699 Thousand | 349.5 Thousand | -5.78 Million |
| Other working capital | -7.41 Million | -7.41 Million | - | 7.76 Million | 4.74 Million | 6.71 Million |
| Cash at beginning of period | 278.87 Million | - | 310.35 Million | 78.1 Million | 78.1 Million | 310.35 Million |
| Cash at end of period | 356.46 Million | 38.79 Million | 278.87 Million | 278.87 Million | 178.49 Million | 78.1 Million |
| Capital Expenditure | -656 Thousand | -656 Thousand | -3.26 Million | -1.1 Million | -550.5 Thousand | -1.96 Million |
| Effect of forex changes on cash | 169.5 Thousand | 169.5 Thousand | -162 Thousand | - | 113 Thousand | - |
| Net cash flow / Change in cash | 77.59 Million | 38.79 Million | -31.48 Million | 200.76 Million | 100.38 Million | -232.24 Million |
| Free Cash Flow | 40.54 Million | 40.54 Million | -32.53 Million | -12.58 Million | -6.29 Million | -19.74 Million |
BFST
MHLXMIRU
6939
7992
WAPO
PREIF